María Teresa Alvarez-Román, MD, PhD

Head of the Haemostasis Unit
Department of Hematology, University Hospital La Paz, Autonoma University of Madrid, Madrid, Spain
Madrid, Madrid, Spain

Presentation(s):

• PB0257 - Cardiovascular disease prevalence and risk factors in patients with haemophilia: results from a single centre cohort study

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0209 - Effectiveness and safety of efmoroctocog alfa (a recombinant factor VIII Fc) across body mass index (BMI) categories: pooled data from two non-interventional phase 4 studies (A-SURE/PREVENT)

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0250 - Exploring clinical profile and patient-reported outcomes of people with non-inhibitor severe hemophilia A: insights from the Spanish cohort of ‘Cost Haemophilia: Socioeconomic Survey’ (CHESS)

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0261 - Investigating effectiveness and safety of extended dosing regimens of damoctocog alfa pegol in the real-world HEM-POWR study

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0237 - Prospective observational study to evaluate the quality of life in patients with Hemophilia A without inhibitors: HEMOLIFE study

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0798 - Age-related changes in coagulation of healthy individuals evaluated by global tests

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• PB0526 - Current challenges in management and implementation of Hemophilia Gene Therapy (HGT) in Spain and Portugal: a survey-based study

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• PB0777 - Platele's function and sialylation in aged individuals

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• OC 50.1 - First interim analysis of clinical outcomes in adults and adolescents with severe hemophilia A receiving efanesoctocog alfa prophylaxis in XTEND-ed, a phase 3 long-term extension study

  Tuesday, June 25, 2024
  09:30 – 09:45 ICT

• PB1020 - Acquired Haemophilia Spanish registry, characteristics of infectious complications after 10 years activity

  Tuesday, June 25, 2024
  13:45 – 14:45 ICT

• PB1285 - Glycosylation and functional defects of platelets from XMEN disease patients

  Tuesday, June 25, 2024
  13:45 – 14:45 ICT

• OC 63.5 - Update on the VWD Clinical and Molecular Profile Project in Spain (PCM-EVW-ES): outcomes from the second recruitment phase

  Tuesday, June 25, 2024
  15:45 – 16:00 ICT